Novel Compounds Having Inhibitory Activity Against Sodium-Dependant Glucose Transporter

Patent No. EP2896397 (titled "Novel Compounds Having Inhibitory Activity Against Sodium-Dependant Glucose Transporter") was filed by Mitsubishi Tanabe Pharma on Jul 30, 2004. The application was issued on Oct 7, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GALENICUM HEALTH SLJun 6, 2018TORREJON NIETO
GENERICS UKJun 5, 2018ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2896397

MITSUBISHI TANABE PHARMA
Application Number
EP14194507A
Filing Date
Jul 30, 2004
Status
Patent Maintained As Amended
Sep 4, 2020
Publication Date
Oct 7, 2020